• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Fusion Pharmaceuticals Acquires IPN-1087

    Strata Oncology Unveils Strata PATH Trial
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    WuXi AppTec Completes OXGENE Acquisition

    Trends in Solid Oral Dosage Delivery

    Injectable Drug Delivery Trends

    Oral Solids: Market & Technology Trends
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Adare Pharma Solutions

    Syngene

    Emergent BioSolutions

    Aphena Pharma Solutions

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami

    Cytovance Biologics

    PCI Pharma Services

    Adare Pharma Solutions

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Technical Advantages of Continuous Flow Chemical Synthesis

    Continuous flow chemistry is known for its ability to handle hazardous reactions safely, but can also unlock many other technological benefits.

    Technical Advantages of Continuous Flow Chemical Synthesis
    Related CONTENT
    • Softweb Solutions
    • Vetio Animal Health
    • Simplifying Recombinant Protein Production: Breaking Down the Corynex Protein Expression System
    • Is Your Complex Formulation Process Set Up for Success?
    • Cambrex Expands Liquid Filling Capabilities
    Shawn Conway, Engineering R&D Director, Cambrex High Point04.05.19
    Continuous flow chemistry has traditionally been used as a safer and more efficient way of handling high energy products and reagents when batch operations were deemed too dangerous. To undertake these in batch mode often requires bunkered production facilities away from main manufacturing areas, while vessel sizes and inventories would be kept low so that in an uncontrolled event, any damage could be easily contained and the risk to personnel and the surrounding area would be limited. However, constructing and maintaining these facilities, together with the small scale of the reactions, can be prohibitively costly.

    Continuous flow processing reduces the effective volume of a unit operation, enhances control and minimizes the exposure and risk so that energetic chemistries or hazardous reagents can be handled safely. It does not eliminate safety concerns entirely, but does reduce the risk factors to levels that are easier to manage and mitigate. Furthermore, by enabling these operations to take place in a regular manufacturing plant they can be linked directly to other downstream processes, giving the advantage of integration of operations.

    Chemical syntheses which have benefited from continuous flow on a commercial level include nitration, where the rapid reaction can be monitored and controlled to ensure the process is efficient and yields high quality product.

    Case Study: Conversion of batch nitration to continuous flow process
    A nitration process that Cambrex converted from batch to continuous processing demonstrates the safety benefits that the technology affords: at its Karlskoga, Sweden facility, the company developed a commercial scale continuous flow process with an annual capacity of more than 50 tons within its regular production facility.

    The intermediate in the reaction itself is highly energetic (more than 2,000 kJ per kilogram), so the process to transfer it into a regular manufacturing facility involved rigorous safety assessments and precautions. Additionally, the nitration reaction is exothermic and requires high cooling capacity to strictly control the temperatures during the reaction.

    Based on the risk profile, a focus of process development was carefully managing both heat and mass transfer to achieve a safe and predictable operation of the process. A formal Design of Experiments (DoE) study was carried out to investigate the impact of key parameters, such as residence time and reaction temperature, on yield and purity to ensure the process can not only be conducted safely but also without sacrificing efficiency or quality.

    Based on the DoE results in conjunction with early development work in the laboratory, the effort to design the nitration reactors began, again with the focus being on maximizing heat and mass transfer. Two continuous stirred tank reactors (CSTRs) were chosen, each with a volume of 15L so that at any single time in the process, the amount of material in each reactor was limited to 5 kg. The arrangement also offered a relatively high surface to volume ratio, which is of course beneficial for the heat transfer. To minimize the risk of any pressure build-up in the event of a runaway reaction, the design of the pressure relief on the reactors was oversized.

    The reaction vessels by design allow high cooling capacity, and the use of small reactors in series limits the amount of product present in each reactor, and thereby the amount of energy stored at any one time.
    To further minimize the risk of explosion, the stoichiometric ratio between the substrate, the solvent and the nitrating agent had to be controlled by monitoring and controlling the ratio between the two feed streams into the nitration reaction, and by interlocking the control system. In an event where the temperature could not be controlled, an emergency quench system was incorporated, utilizing a pre-pressurized tank that could release water into the nitration vessel. As yet another level of process safety, the equipment was also designed to withstand the gas evolution associated with a complete decomposition of the reactants in the vessel.

    Development of continuous flow processes: overcoming challenging conditions
    The previous case study is an excellent example of the importance of both heat transfer and mass transfer (mixing) for chemical processes, with respect to both quality and process safety. It also illustrates the enabling power that continuous flow can provide in managing or even enhancing these key process attributes. Looking into this further, controlling temperature is critical to a successful scale-up within a process development or commercialization cycle, and this is particularly true when dealing with exotherms within a reaction. The impact of scale is seen when looking at the ratio of heat transfer surface area to the overall reactor volume. In general, the ratio drops by at least an order of magnitude when a process is scaled up from a laboratory or pilot demonstration batch to a modestly sized production run.

    This drop in the ratio hinders the ability to remove the excess heat from the reaction mixture, possibly putting the material at risk as it reaches a temperature limit. It can also lead to localized hot spots within the mixture, which can cause inconsistency and non-homogeneity.

    The reduction in the surface area to volume ratio is still present in the scale-up of a flow process, however that ratio is considerably larger for a tube reactor. For example, a 4-inch diameter tube has approximately the same ratio as a typical 0.5 liter laboratory reactor; while more typical tube or pipe reactor diameters will have considerably higher values, ensuring that temperature control and exotherm management can be handled in a straightforward manner.

    In some cases, it may be advantageous to purposely increase the process temperature. With regard to reaction kinetics, in general, the reaction rate doubles for every increase in 10 degrees of absolute temperature, but at larger scale in batch processing there are several pitfalls to elevated temperatures. Firstly, as with elevated process pressure, elevated process temperatures often require a much more expensive infrastructure which will be exacerbated by inefficient mixing in large reactors, extending reaction times and negating any process time gains resulting from the accelerated kinetics of a higher temperature.

    Secondly, after a reaction is completed at elevated conditions the process is typically returned to ambient or near-ambient conditions for quenches, work-ups and subsequent process steps. The large thermal mass in a batch reactor takes a considerable amount of time to adjust, which not only further erodes process time gains but also exposes the reaction mixture to extreme conditions for an extended period of time.

    Finally, higher temperatures may have undesirable effects on reaction selectivity, while also significantly increasing the risk profile and potential dangers with solvents being raised to or above flash points and reaction mixtures purposely being raised to the point where runaway conditions or over-pressure conditions are a real possibility.

    Continuous flow reactions, using smaller, instantaneous volumes drastically minimize mixing impacts and concentration or temperature gradients, and also bring the amount of material that has an elevated risk status to a much more manageable level. Furthermore, the reduced thermal mass makes the process of temperature quenching orders of magnitude quicker, allowing for a rapid introduction to elevated conditions to drive kinetics, followed by a rapid return to ambient conditions for further processing or to protect the integrity of the products or intermediates that are being formed.

    At the other end of the spectrum, traditional batch equipment is limited when cryogenic conditions are necessary, for example when stereoselectivity needs to be controlled, or to protect unstable intermediates. Maintaining cryogenic temperatures efficiently and consistently is difficult and multiple low temperature thermal cycles can have a detrimental impact on the equipment itself and lead to stress cracking and premature equipment failure. Using a liquid nitrogen injection as an alternative to drive cryogenic conditions is difficult to control and can become very costly at scale.

    An example of an industrially relevant process that typically requires cryogenic conditions is lithiation chemistry. The previously discussed advantages of continuous flow can certainly be utilized to improve the performance of lithiations, but another alternative is replacement by Grignard reactions to avoid the problems of maintaining low temperatures. However, these bring different challenges as they are energetic and extremely air and moisture sensitive, and often necessitate the use of pyrophoric and short shelf-life reagents. Converting Grignard reactions to a continuous process allows much more efficient and safe synthesis, as the reagents can be manufactured in a just-in-time manner.

    Just as with temperature, pressure can also be a powerful process parameter that can be harnessed with continuous flow processes. Hydrogenation is a widely used synthetic tool thats use can be limited by batch processing and restrictions of standard plant equipment. The pressure requirements for hydrogenations can typically be 100-150 psig (although pressures higher than 300 psig are not uncommon), and often involve expensive catalysts and lengthy reaction times.

    Flow hydrogenation has become an increasingly investigated and accepted technology to solve these issues, and strategies and technologies are available allowing for both homogeneous and heterogeneous catalyst processes. Tube reactors and packed bed columns are readily adaptable to much higher processing conditions, easily achieving pressures 10 times that of standard batch reactors. Strategies also exist for replenishing supported catalysts that are consumed over the course of a process, utilizing multiple columns with diverters or automating a semi-batch/semi-continuous process with multiple catalyst charges. By these means, a throughput of several kilograms in a day is readily achievable with a modest equipment footprint.

    Improved product quality
    While the case study focused on process safety concerns, the need to maintain quality standards was also a key consideration. Certainly, consistent quality performance during a transition from a batch to a continuous process must be maintained, at a minimum. However, an important benefit that continuous flow can afford in some situations is improved quality of the final product. Frequently, a process chemist or engineer is forced to accept a less than ideal synthetic route due to infrastructure constraints, such as achievable pressures, temperatures, addition rates or equipment availability within a plant. These processes can generate impurities that must be removed, and in some situations the majority of an industrial process may be more focused on removing impurities rather than actually making the desired product.

    In some cases, flow chemistry can avoid these impurities, or at least reduce them significantly, as the process can be designed to minimize their formation, and analysis can be integrated into the process rather than functioning as a separate operation.

    In a continuous flow process, introducing process analytical technology (PAT) for more sophisticated analysis is generally easier than for batch production: often only temperature probes and flow meters are required to ensure that the process remains within the acceptable parameters to afford product of a known quality. Sophisticated PAT probes can be easily integrated into a flow process to allow for rapid detection of deviations, in addition to nearly continuous monitoring of instantaneous quality, as opposed to waiting on a single batch sample and corresponding measurement.

    These PAT probes can be used to monitor process performance attributes, such as reaction conversion, with the data being utilized to make real-time adjustments, correcting for process variations. Fourier-transform infrared (FTIR) spectroscopy can be used to map reaction kinetics during process development, and then subsequently incorporated into flow streams for real-time monitoring of conversion. Peak depletion or peak growth can be used during development to define optimal conditions, with standardized peak intensity, then being used online during campaigns to monitor for deviations and to develop an online process control response. Similarly, with Raman spectroscopy, tracking wave numbers can be used to monitor reaction conditions; however, it adds an intriguing functionality, as different polymorphs of a substance have unique spectra, enabling its use in a crystallization or precipitation process to ensure that the desired form is produced.

    However, chromatographic analysis remains the standard for analytical measurements, and as a result, equipment has been developed to perform these analyses as close to real-time as possible.  An added feature is that when a sample is pulled, it is typically representative of the entire flow stream, which, by definition is a complete representation of the reaction mixture in that instantaneous moment, eliminating potential concerns over a sample being truly representative.

    The PAT data can be used to ensure the process is operating within its targeted window and often allows for a process incorporating a single flow step to be embedded in a larger process, while still fitting comfortably within well-established quality systems that exist in most manufacturers.

    Although it might not be applicable for all reactions and all conditions, for continuous flow to achieve successful widespread implementation, it must be seen as a technology of choice and not just a niche problem-solving option for energetic reactions. Along those lines, a number of pharmaceutical companies have invested in, and are actively investigating the use of continuous flow. Moving forward, as products come to market that have utilized the technology, undoubtedly there will be greater adoption to leverage the advantages that it brings. 
    Related Searches
    • it
    • quality
    • facility
    • process control
    Suggested For You
    Softweb Solutions Softweb Solutions
    Vetio Animal Health Vetio Animal Health
    Simplifying Recombinant Protein Production: Breaking Down the Corynex Protein Expression System Simplifying Recombinant Protein Production: Breaking Down the Corynex Protein Expression System
    Is Your Complex Formulation Process Set Up for Success? Is Your Complex Formulation Process Set Up for Success?
    Cambrex Expands Liquid Filling Capabilities Cambrex Expands Liquid Filling Capabilities
    MilliporeSigma Opens New M Lab Collaboration Center in France MilliporeSigma Opens New M Lab Collaboration Center in France
    VGXI Achieves Tech Transfer Milestones VGXI Achieves Tech Transfer Milestones
    Industry 4.0 in the Pharma Industry Industry 4.0 in the Pharma Industry
    Fluid Bed & Melt Granulation in Pharma Manufacturing Fluid Bed & Melt Granulation in Pharma Manufacturing
    Preparing For Your CDMO Selection Process Preparing For Your CDMO Selection Process
    Central Pharma Partners with Supply Chain Wizard Central Pharma Partners with Supply Chain Wizard
    OPTIMA, Coatema Introduce COMEDCO Machine System OPTIMA, Coatema Introduce COMEDCO Machine System
    Parker Bioscience Opens New Testing Facility Parker Bioscience Opens New Testing Facility
    Boehringer, IBM Explore Blockchain Technology in Clinical Trials Boehringer, IBM Explore Blockchain Technology in Clinical Trials
    Vetter Corporate Brochure Vetter Corporate Brochure

    Related Features

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    • Drug Development | Drug Discovery | R&D
      R&D Outsourcing Trends

      R&D Outsourcing Trends

      Highly specialized drug products and capacity needs drive increased reliance on contract service providers.
      Kristin Brooks, Managing Editor, Contract Pharma 10.14.20

    • Drug Development | Preclinical Outsourcing
      Preclinical Planning for Successful Drug Development

      Preclinical Planning for Successful Drug Development

      When the preclinical pressure is on, appropriate planning can make sure timelines are achievable.
      Mingyi Trimble, WuXi AppTec 09.09.20


    • APIs | Drug Development | Risk Management
      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-molecule drug development has become more complex and challenging, leading to greater reliance on CDMOs.
      Sarah Bethune, Cambrex 09.09.20

    • Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
      Expediting a COVID-19 Vaccine: FDA Approval Process

      Expediting a COVID-19 Vaccine: FDA Approval Process

      The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.
      Kristin Brooks, Managing Editor 09.09.20

    • Drug Development | Regulatory Affairs
      Guidelines in Toxicology: A Blessing and a Curse

      Guidelines in Toxicology: A Blessing and a Curse

      A look at the evolution of drug development regulatory guides.
      Sarah Gould, Senior Principal Scientific Advisor, Charles River 09.16.19


    • Drug Development
      Flex Your Outsourcing Model to Maximize Drug Development

      Flex Your Outsourcing Model to Maximize Drug Development

      How to choose—and optimize—combinations of service models to fit your needs.
      Timothy King, Executive Director, Functional Service Partnerships (FSP), PPD 09.16.19

    • Biologics, Proteins, Vaccines | Drug Delivery | Drug Development
      Knowledge Sharing: Biologics Development and Delivery

      Knowledge Sharing: Biologics Development and Delivery

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development.
      Fran L. DeGrazio, Vice President of Scientific Affairs and Technical Services, West Pharmaceutical Services 09.16.19

    • Drug Development
      Improving Your Development Program

      Improving Your Development Program

      Seven lab science trends driving the future of drug development.
      Jenifer Vija, Liam Moran, Chris Loosbroock and Eric Snyder, Charles River 05.07.19


    • Drug Development | Preclinical Outsourcing
      Early Development Trends

      Early Development Trends

      Catalent’s president of oral drug delivery, Jonathan Arnold, talks trends and challenges in the early phases of drug development.
      Tim Wright, Editor, Contract Pharma 03.06.19

    • Drug Development
      Future Trends in the CDMO Space

      Future Trends in the CDMO Space

      And how to navigate them for successful drug development
      Guillaume Plane, Global Development and Marketing Manager, BioReliance End-to-End Solutions, MilliporeSigma 01.25.19

    • APIs | Cytotoxics and High Potency Manufacturing | Drug Development
      CDMOs On The Rise

      CDMOs On The Rise

      Tracking growth and strategies in the CDMO business
      Michel Le Bars, Managing Partner, Kurmann Partners AGe 01.25.19


    • Drug Development | Formulation Development
      Abuse Deterrent Formulations

      Abuse Deterrent Formulations

      A look at opioid abuse in North America and formulations to help avoid an epidemic.
      Damon Smith, Richard Dart and Christopher Hirst 11.13.18

    • Drug Development
      Streamlining Drug Development:

      Streamlining Drug Development:

      Four key takeaways from Veeva’s 2018 R&D Summit
      Henry Levy, General Manager of Vault CDMS, Veeva Systems 11.13.18

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Haste Makes Waste

      Haste Makes Waste

      When to sprint and when to breathe in the race from lab to clinic.
      Christian Cattaruzza, MilliporeSigma 09.11.18

    Trending
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Bormioli Opens New Glass Research Center
    • WuXi AppTec Completes OXGENE Acquisition
    • Arcline Investment Acquires ChargePoint Technology
    Breaking News
    • Innoforce and dMed Enter Development Collaboration
    • Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    • Four Female Leaders Appointed to Cell & Gene CDMO
    • Fusion Pharmaceuticals Acquires IPN-1087
    • Strata Oncology Unveils Strata PATH Trial
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Study Explains Link Between Probiotic Strains and Children’s Immune Health Benefits
    Maypro Launches Brain Heatlh Ingredient NeuroHD
    Gadot Biochemical Launches New Magnesium Ingredients
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Matt Fogel Named Mule-Hide's Territory Manager – Southern Virginia
    Benjamin Moore Launches COMMAND
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Ready Robotics Hires Proven Automation Leaders
    Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety
    FDA OKs Asensus' Senhance for General Surgery
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Innoforce and dMed Enter Development Collaboration
    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    Four Female Leaders Appointed to Cell & Gene CDMO
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    BizBash Names Unfiltered Experience ‘People's Choice: Best Influencer Event’
    P&G Makes Progress Toward Packaging Circularity in Europe
    Coty Partners with LanzaTech to Introduce Sustainable Ethanol
    Happi

    Latest Breaking News From Happi

    Uoma Beauty Unveils a 'Coming 2 America' Makeup Collaboration
    Coty Partners with LanzaTech to Reduce Its Environmental Impact
    Waterless Beauty, Simplified Routines Shape Clean Beauty at Whole Foods
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Fort Dearborn Company acquires Hammer Packaging
    Ashland announces PSA price hike in North America
    Arrow Systems and Sihl form flexible packaging partnership
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Joa Announces Expandable Absorbent Core Wrap Solution
    Principle Business Enterprises Celebrates 60 Years
    Mann+Hummel Invests in Pamlico Air
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lincotek Medical Expands Coatings and Additive Capacity
    Spinal Elements Relaunches the Luna XD and Orbit Systems
    Coronavirus Triggers Double-Digit Revenue Dropoff at Smith+Nephew
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login